Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for gastrin 17 (compound)
Most Correlated Studies
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- Gastrin induced gene expression in AR42J cells with and without protein synthesis
Most Relevant Literature
- Reference Interval of Serum Gastrin 17 (G-17) for Healthy Population: A Non-Invasive Screening Bioma…
- Development of amplified luminescent proximity homogeneous assay for quantitation of gastrin-17.
- Analysis of gastrin-17 and its related influencing factors in physical examination results.
- Nanozyme enhanced magnetic immunoassay for dual-mode detection of gastrin-17.
- B12 deficiency-related glossitis is highly associated with high gastrin-17 and low pepsinogen I.
Most Relevant Clinical Trials
- Improving Islet Transplantation Outcomes With Gastrin
- Trial of a Gastrin Receptor Antagonist in Barrett's Esophagus
- Two Center Study to Determine Effect of G17DT on Plasma Gastrin Levels in Patients With Colorectal C…
- [68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide…
- Study to Assess Safety and Tolerability of G17DT in Patients With Colorectal Adenocarcinoma.
